IM Cannabis Corp. (CSE: IMCC)

Market Cap	11.13M
Revenue (ttm)	51.39M
Net Income (ttm)	-12.86M
Shares Out	2.97M
EPS (ttm)	-5.76
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	3.740
Previous Close	3.740
Day's Range	3.740 - 3.740
52-Week Range	1.440 - 10.680
Beta	1.68
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About IM Cannabis

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2008
• Employees: 95
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: IMCC

Financial Performance

In 2023, IM Cannabis's revenue was 48.80 million, a decrease of -10.18% compared to the previous year's 54.34 million. Losses were -9.50 million, -94.97% less than in 2022.